RecruitingNCT07653269

Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation

Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation - PRIME Study


Sponsor

Singapore National Eye Centre

Enrollment

1,500 participants

Start Date

Oct 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research study is to evaluate a new screening procedure for the early detection and monitoring of Age-related Macular Degeneration (AMD) in community settings and community hospital settings, to identify associated risk factors, and develop personalized monitoring strategies for at-risk individuals throughout the 5 years follow up period, which will allow us to establish prevalence, natural history of progression of early AMD in the community.


Eligibility

Min Age: 55 Years

Inclusion Criteria4

  • Adults aged 55 years or older
  • No severe systemic illnesses that prevent study participation
  • Willing and able to undergo protocol-required procedures for both eyes
  • Willing and able to provide written informed consent

Exclusion Criteria3

  • Systemic disorders that preclude reliable clinical examination or multimodal imaging
  • Poor compliance or severe mental illness that hinders participation
  • Persons who are unable to give informed consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Outram Community Hospital

Singapore, Singapore

Singapore National Eye Centre/ Singapore Eye Research Institute

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07653269


Related Trials